Skip to main navigation Skip to search Skip to main content

Phase II study of concurrent continuous temozolomide (TMZ) and tamoxifen (TMX) for recurrent malignant astrocytic gliomas

Alexander M. Spence, Richard A. Peterson, Jeffrey D. Scharnhorst, Daniel L. Silbergeld, Robert C. Rostomily

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of concurrent continuous temozolomide (TMZ) and tamoxifen (TMX) for recurrent malignant astrocytic gliomas'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science